GSK reports good results from clinical trials of gonorrhea drug
[ad_1]
Today, February 26, the British pharmaceutical company GSK reportedthat the medicine she developed for the treatment of gonorrhea turned out to be as effective as the intramuscular injections used now. GSK made this statement based on the results of the third stage of clinical trials of the drug.
We are talking about the antibiotic gepotidacin developed by GSK, taken in tablet form. Typically, when treating gonorrhea, the drug ceftriaxone is prescribed in the form of an intramuscular injection or its combination with other medications. GSK said the new drug could be particularly useful for patients with gonorrhea that is resistant to other drugs or who are intolerant to other drugs. The company is also testing the effect of gepotidacin in the treatment of other diseases, including diseases of the genitourinary system.
By data According to the World Health Organization, more than 82 million new cases of gonorrhea infection are recorded annually in the world, and the incidence is growing. In the US alone, the number of cases of the disease doubled from 2009 to 2022. having reached 648 thousand
[ad_2]
Source link
